Mapmygenome
Hyderabad, India· Est.
India’s leading consumer‑focused genomics platform delivering personalized health insights through at‑home DNA testing and expert counseling.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $40M
AI Company Overview
India’s leading consumer‑focused genomics platform delivering personalized health insights through at‑home DNA testing and expert counseling.
Preventive HealthPharmacogenomicsMicrobiomeAgingMetabolic Health
Technology Platform
High‑throughput NGS (whole‑genome, metagenomic shotgun, DNA‑methylation, mitochondrial DNA) combined with AI‑driven bioinformatics and certified genetic counseling.
Opportunities
Expansion into corporate wellness programs, tele‑medicine integration, and international e‑commerce can accelerate growth; AI‑enhanced risk prediction and longitudinal health tracking will deepen customer engagement.
Risk Factors
Regulatory changes around genetic data privacy, competition from global genomics firms entering India, and reliance on consumer willingness to pay for preventive testing pose significant risks.
Competitive Landscape
Key competitors include 23andMe, MyHeritage, and local player HealthifyMe; Mapmygenome differentiates through India‑specific population data, accredited clinical labs, and bundled genetic counseling services.